Abstract
New ferrocenic 4-aminoquinoline urea compounds have been tested for inhibition of trypanothione reductase (TryR) and human glutathione reductase (GR). Several compounds were also tested in vitro against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei rhodesiense. All compounds showed significant improvement in inhibition of TryR relative to chloroquine with the best compound showing an IC50 value of 2.4 mu M (Chloroquine IC50 = 47.6 mu M).
| Original language | English |
|---|---|
| Pages (from-to) | 52-60 |
| Number of pages | 9 |
| Journal | ARKIVOC |
| Volume | 2008 |
| Issue number | vi |
| Publication status | Published - 2008 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Ferroquine
- 7-chloroquinoline
- urea
- in vitro
- trypanothione reductase
- ACTIVITY IN-VITRO
- TRYPANOSOMA-CRUZI
- CRITHIDIA-FASCICULATA
- ANALOGS
- ANTIPROTOZOAL
- LEISHMANIA
- QUINACRINE
- DISCOVERY
- MALARIA
- DESIGN
Fingerprint
Dive into the research topics of 'Inhibition of trypanothione reductase and glutathione reductase by ferrocenic 4-aminoquinoline ureas'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver